More public education and guidelines are needed to increase marijuana users’ understanding of cannabis-related driving impairment
Recreational cannabis is legal in 10 states and Washington, D.C., but regulations regarding potency do not exist. The results of a new study, led by an Iowa State University researcher, may prompt states to reconsider.
Interest has been growing in the use of cannabinoids—the active chemicals in cannabis or marijuana— for the treatment of epilepsy in children.
It’s well established that secondhand smoke from cigarettes is a risk to anyone who suffers from asthma. New research being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting shows it’s possible for both children and adults with uncontrolled asthma to find their symptoms worsening due to cannabis allergy and exposure to marijuana smoke.
In recent years, cannabinoids—the active chemicals inmedicalmarijuana— have been increasingly touted as a potential treatment for a range of neurological and psychiatric disorders. In a Developmental Medicine & Child Neurology review, investigators compare their efficacy with antiepileptic drugs for children with epilepsy.
Long-term use of either cannabis or cannabis-based drugs impairs memory say researchers.
The study has implications for both recreational users and people who use the drug to combat epilepsy, multiple sclerosis and chronic pain.